This brand name is authorized in Nigeria.
The drug FEXOPOXIME contains one active pharmaceutical ingredient (API):
1
|
UNII
97I1C92E55 - CEFIXIME
|
|
Cefixime is an oral third generation cephalosporin which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| C4-1989 | Tablet | Fexopoxime 400 Tablets TAB 400 mg 1 x 10's (in Alu-Alu blister) | Tablet White color, oblong biconvex and film coated tablet. One side smooth and other side mid divide line Fexopoxime 400 Tablets C4-1989 Fexopoxime CEFIXIME TRIHYDRATE PRESCRIPTION ONLY MEDICINE ANTIBIOTIC CEFIXIME TRIHYDRATE USP EQV TO CEFIXIME (ANHYDROUS) 400MG TABLETS 1 X 10 TREATMENT OF SUSCEPTIBLE INFECTIONS FEXONA PHARM CO LTD NIGERIA ZEE LABORATORIES LTD INDIA 05/26/2022 05/25/2027 | 26/05/2022 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DD08 | Cefixime | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | C4-1989 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.